Glipizide and Injection site rash - a phase IV clinical study of FDA data

Summary:

Injection site rash is reported as a side effect among people who take Glipizide (glipizide), especially for people who are female, 60+ old, also take Metformin, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Injection site rash when taking Glipizide. It is created by eHealthMe based on reports of 63,661 people who have side effects when taking Glipizide from the FDA, and is updated regularly.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 64,852 Glipizide users. Check the latest studies of Glipizide.

What is Injection site rash?

Injection site rash is found to be associated with 709 drugs and 713 conditions by eHealthMe. Check the latest studies of Injection site rash.

On Jul, 05, 2026

63,661 people reported to have side effects when taking Glipizide.
Among them, 87 people (0.14%) have Injection site rash.

Could Glipizide cause Injection site rash?

Among these 87 people:

What is the gender of people who have Injection site rash when taking Glipizide? *

female: 69.14 %
male: 30.86 %

What is the age of people who have Injection site rash when taking Glipizide? *

What are other drugs people take besides Glipizide? *

What are other side effects people have besides Injection site rash? *

Injection Site Pruritus (severe itching at injection site): 24 people, 27.59%
Injection Site Bruising: 16 people, 18.39%
Injection Site Pain: 12 people, 13.79%
Weight Decreased: 12 people, 13.79%
Nausea (feeling of having an urge to vomit): 11 people, 12.64%
Injection Site Erythema (redness at injection site): 9 people, 10.34%
Injection Site Haemorrhage (bleeding from injection site): 9 people, 10.34%
Blood Glucose Increased: 9 people, 10.34%
Fatigue (feeling of tiredness): 8 people, 9.20%
Drug Ineffective: 8 people, 9.20%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 11.49%
High Blood Pressure: 6 people, 6.90%
High Blood Cholesterol: 4 people, 4.60%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 4.60%
Indigestion: 3 people, 3.45%
Multiple Myeloma (cancer of the plasma cells): 3 people, 3.45%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 3.45%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 2.30%
Muscle Spasms (muscle contraction): 2 people, 2.30%
Hepatitis C: 2 people, 2.30%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and have Injection site rash?

- Check whether Injection site rash is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glipizide:

Glipizide (64,852 reports)

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site rash:

Injection site rash (709 drugs)

Browse all the conditions that are associated with Injection site rash:

Injection site rash (713 conditions)

Related publications that referenced our studies

Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .
Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on glipizide (the active ingredients of Glipizide) and Glipizide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.